About Us

Headshot of Kitty Yale

Kitty Yale

Kitty Yale is Chief Development Officer of Akero Therapeutics. Yale joins Akero from Gilead Sciences, Inc. where she led global clinical operations and management of the company’s oncology, HIV, inflammation and liver disease trials. Prior to joining Akero, Kitty held senior clinical research and operations roles at Gilead Sciences and Roche Global Development. Most recently, as VP of Clinical Operations at Gilead, she led global development programs resulting in eight drug approvals in the US, EMEA, Canada, Korea, Japan and China.

© 2019 Akero Therapeutics, Inc. All rights reserved. Terms of Use.